Acadia Healthcare's (ACHC) revised long-term growth targets are "reasonable" as they reflect the longer ramp of new facilities, RBC Capital Markets said in a Tuesday note.
The company provided additional commentary on its revised long-term outlook, saying that the lower-than-expected earnings before interest, taxes, depreciation, and amortization was mainly related to the longer ramp of new facilities compared to expansion beds, RBC analysts noted.
Acadia management also pointed out conservatism related to rate growth assumptions, given uncertainty surrounding policy and the macro environment, the analysts said.
The analysts said the company's clarifications "comprise a reasonable basis" for the revised long-term outlook.
RBC maintained its outperform rating and $43 price target on the stock.
Price: 23.04, Change: -0.48, Percent Change: -2.04
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.